Sarepta Therapeutics (SRPT) Other Non-Current Assets (2010 - 2026)

Sarepta Therapeutics' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $4.1 million for Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 73.55% year-over-year to $4.1 million in Q1 2026; TTM through Mar 2026 was $4.1 million, a 73.55% decrease from a year earlier, with the FY2025 full-year figure at $5.2 million, up 354.47% from the prior year.
• Other Non-Current Assets fell to $4.1 million in Q1 2026 per SRPT's latest filing, from $5.2 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $278.6 million in Q1 2022 and bottomed at $1.1 million in Q4 2024.
• The 5-year median for Other Non-Current Assets is $5.2 million (2025), against an average of $47.6 million.
• Across the five-year window, Other Non-Current Assets jumped 13019.07% in 2022 and plunged 99.17% in 2024, its largest moves.
• Year by year, Other Non-Current Assets stood at $2.2 million in 2022, then surged by 6261.44% to $136.8 million in 2023, then plunged by 99.17% to $1.1 million in 2024, then surged by 354.47% to $5.2 million in 2025, then retreated by 20.62% to $4.1 million in 2026.
• Per Business Quant, the three latest SRPT Other Non-Current Assets figures stand at $4.1 million (Q1 2026), $5.2 million (Q4 2025), and $73.4 million (Q3 2025).